Persistent omental trophoblastic implantation following salpingostomy, salpingectomy and methotrexate for ectopic pregnancy: A case report
2% of all pregnancies are ectopic. Optimal surgical management is currently salpingectomy over salpingostomy, secondary to the risks of persistent trophoblastic tissue or omental implants (15%). However, rare cases of omental trophoblastic implants following laparoscopic salpingectomy have been note...
Gespeichert in:
Veröffentlicht in: | Case reports in women's health 2019-01, Vol.21, p.e00095, Article e00095 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 2% of all pregnancies are ectopic. Optimal surgical management is currently salpingectomy over salpingostomy, secondary to the risks of persistent trophoblastic tissue or omental implants (15%). However, rare cases of omental trophoblastic implants following laparoscopic salpingectomy have been noted in the literature. Current practice dictates that serial determinations of human chorionic gonadotropin (beta-hCG) levels after salpingectomy are not required, as it is considered a definitive treatment. However, given that these cases are hard to interpret through ultrasound and are almost always detected via sudden-onset abdominal pain and acute haemoperitoneum (33%), an argument can be made for post-operative beta-hCG assessment.
•A case of persistent trophoblastic omental deposits following attempted salpingostomy and subsequent salpingectomy of an ectopic pregnancy.•Ongoing raised human chorionic gonadotropin (beta-hCG), treated with methotrexate, resulted in haemoperitoneum, requiring operative management.•Follow-up beta-hCG levels following attempted salpingostomy should be routinely performed. |
---|---|
ISSN: | 2214-9112 2214-9112 |
DOI: | 10.1016/j.crwh.2019.e00095 |